As a retail investor, I do not wish to see so-called Complex Products subject to additional regulation. Every major trading platform provides lengthy disclosures about these products. All investors using these products already have the tools necessary to understand them and become familiar with the risks if they so choose. Further restricting access to these products by ordinary investors benefits no one, particularly if wealthy investors end up subject to fewer or no restrictions. Complex Products have unique advantages and their availability should not favor some over others.
Any restrictions will reduce trading volume, which limits information available to market participants and impairs the efficiency of markets to the detriment of all. Perversely, additional regulation may increase the risk of these products, since assets under management in certain products would presumably shrink as fewer investors would be permitted to trade.
Adequate disclosure and reasonable access to information are the only special protection investors need. Existing rules appear to be more than sufficient.
For the Public
FINRA DATA
FINRA Data provides non-commercial use of data, specifically the ability to save data views and create and manage a Bond Watchlist.
For Industry Professionals
FINPRO
Registered representatives can fulfill Continuing Education requirements, view their industry CRD record and perform other compliance tasks.
For Member Firms
FINRA GATEWAY
Firm compliance professionals can access filings and requests, run reports and submit support tickets.
For Case Participants
DR PORTAL
Arbitration and mediation case participants and FINRA neutrals can view case information and submit documents through this Dispute Resolution Portal.
Need Help? | Check System Status
Log In to other FINRA systems
Nathan Ray Comment On Regulatory Notice 22-08
As a retail investor, I do not wish to see so-called Complex Products subject to additional regulation. Every major trading platform provides lengthy disclosures about these products. All investors using these products already have the tools necessary to understand them and become familiar with the risks if they so choose. Further restricting access to these products by ordinary investors benefits no one, particularly if wealthy investors end up subject to fewer or no restrictions. Complex Products have unique advantages and their availability should not favor some over others.
Any restrictions will reduce trading volume, which limits information available to market participants and impairs the efficiency of markets to the detriment of all. Perversely, additional regulation may increase the risk of these products, since assets under management in certain products would presumably shrink as fewer investors would be permitted to trade.
Adequate disclosure and reasonable access to information are the only special protection investors need. Existing rules appear to be more than sufficient.